SIGLEC6 and colorectal carcinoma: The tight association of high levels of BTLA, FCRL4, SIGLEC2 and SIGLEC6 (107) with the B lymphocyte markers, CD19, CD20 and CD79a, along with their negative prognostic value, strongly suggests a role for exhausted B lymphocytes in CRC immune escape and patient outcome.